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Snn lm~.ry  
The dassical minor lymphocyte stimulating (Mls) antigens, which induce a strong primary T 
cell response invitro, are closely linked to endogenous copies of mouse mammary tumor viruses 
(MMTV). Expression of Mls genes leads to clonal deletion of T cell subsets expressing specific 
T cell receptor (TCR) Va chains. We describe the isolation and characterization f a new 
exogenous (infectious) MMTV with biological properties similar to the Mls antigen Mls-l'. 
In vivo administration f either Mls-l'-expressing B cells or the infectious MMTV (SW) led 
to an increase of T cells expressing Va6 followed by their deletion. Surprisingly, different kinetics 
of deletion were observed with the exogenous virus depending upon the route of infection. Infection 
through the mucosa led to a slow deletion of Va6 + T cells, whereas deletion was rapid after 
subcutaneous infection. Sequence analysis of the open reading frames in the 3' long terminal 
repeat of both this exogenous MMTV (SW) and of Mtv-7 (which is closely linked to Mls-19 
revealed striking similarities, particularly in the COOH terminus, which has been implicated 
in TCR Va recognition. The identification of an infectious MMTV with the properties of a 
strong Mls antigen provides a new, powerful tool to study immunity and tolerance in vivo. 
T he Mls antigens were originally defined on the basis of a very strong proliferative T cell response between MHC- 
identical mouse strains (1). Several independent Mls loci (M/s-l, 
-2, -3, -4) segregating assingle autosomal dominant genes 
have been defined (for review see reference 2). For each Mls 
locus, a stimulating (named, e.g., Mls-1 a) and a null (named, 
e.g., Mls-1 b) allele has been described. 
T cell reactivity towards Mls gene products appears to be 
determined xclusively by the V domain of the TCR/3 chain 
(3-8), whereas the variable, junctional, and highly poly- 
morphic CDR3 segments of both the TCR ol and/3 chains 
determine classical recognition of antigenic peptides associated 
with MHC molecules (for review see reference 9). 
Because of their unique Va specificity, Mls antigens have 
been key elements in the development of our current under- 
standing of tolerance mechanisms in mice. T cells expressing 
Mls-reactive TCK Va domains are deleted in an Mls-expres- 
sing mouse strain during thymic maturation by a mechanism 
called negative selection. Thus, carriers of the Mls-P gene 
delete T cells expressing TCR Va6, 7, 8.1, and 9 from their 
1 The first two authors contributed equally to this work. 
peripheral T cell pool as a consequence of self-reactivity (3, 
4, 10,11). 
A second tolerance mechanism has been shown to operate 
for Mls antigens: injection of Mls-la-expressing cells into 
adult Mls-1 b mice leads to a specific unresponsiveness to 
Mls-1 ~ with or without subsequent peripheral deletion of 
the reactive T cell subsets (12-14). 
In addition to Mls genes, several other genetic dements 
were described that delete T ceils from the peripheral T cell 
pool depending on the expression of their TCR V~ do- 
mains. However, these deletion dements were found to be- 
have differently from Mls-P. First, in agreement with ear- 
lier proliferation studies (15, 16, and for review see reference 
2), I-A as well as I-E can present Mls-P for donal deletion 
in vivo (3, 4), whereas these other deletion dements strictly 
require I-E expression for donal deletion to occur (17-26, 
and for review see reference 27). Second, a strong prolifera- 
tive T cell response in vitro can be induced with Mls-la- 
expressing B cells (28-30). Such a proliferative response of 
T ceils expressing the relevant TCR V~ domains was not de- 
tected (or only very weakly) with these weaker ddetion ele- 
ments. Third, Mls-1 ~ mice delete Va6 cells very quickly after 
birth (31). This is in contrast to the weaker deletion elements, 
where a much longer amount of time is required to induce 
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a near complete deletion (32, 33). Thus, for the rest of this 
article, these weak deletion dements will be referred to as 
Mls-like determinants. 
It has been shown recently that the gene products encoding 
most (if not all) Mls and Mls-like determinants in mice are 
dosdy linked to endogenous mouse mammary tumor virus 
(MMTV) z proviral loci (32, 34-37). Until now, >30 
different endogenous MMTVs have been mapped and charac- 
terized (38). They display •95% nucleotide sequence ho- 
mology. Usually, two to eight different MMTV copies are 
contained inthe genome of any inbred hboratory mouse strain. 
One of these copies, Mtv-7, showed ose linkage to Mls-1 ' 
(32, 36). Results from transgenic mice as well as transfection 
experiments showed that this deleting activity is encoded by 
a 3' open reading flame (off) within the LTR of MMTV 
(32, 39). Sequence comparison and transgenic mouse xperi- 
ments further suggested that the specificity for particular TCR 
V~ domains is localized at the COOH-terminus of these 
putative MMTV off molecules (32, 39, and for review see 
reference 27). 
MMTV also exists as an exogenous infectious virus that 
is maternally transmitted via milk (40). Our knowledge about 
the biology and the life cycle of the virus is still incomplete. 
Uptake of the virus occurs in the gut. There is some evi- 
dence that the immune system is involved in transport of the 
virus to the mammary gland (41). Upon infection of the mam- 
mary gland, the virus can complete its life cycle. Integration 
close to the int-1, -2, -3, and -4 loci leads to development of
mammary tumors and high MMTV titers in milk (42). 
With respect to donal deletion of T cells expressing specific 
Va chains, the two exogenous MMTVs (GR) and (C3H) 
have been characterized, MMTV (C3H) was shown to in- 
duce a slow deletion of T cells expressing V~14 after neo- 
natal uptake of infectious particles contained in milk (33). 
MMTV (GR) has been analyzed using mice containing the 
entire viral genome as a transgene. In these transgenic mice, 
MMTV (GR) leads to a slow, I-E-dependent ddetion of 
V014 + T cells (32). Neither virus is capable of stimulating 
a strong mixed lymphocyte response. Thus, exogenous 
MMTVs behave very much like the weak Mls-like structures 
described above. So far no infectious virus encoding astrong 
Mls antigen has been described. 
In this article we describe the characterization f an exog- 
enous form of Mls-l'. This infectious MMTV was found in 
high titers in the milk of several but not all BALB/c mice 
obtained from IFFA Credo (BALB/c IC), but not in BALB/c 
mice obtained from Harlan Olac (BALB/c HO). It induces 
clonal ddetion of the same TCK V0-expressing T cells as 
MIs-P. Either fast or slow donal deletion of the responsive 
T cells was observed epending on the route of infection. 
Analysis of the DNA or cDNA sequences ofboth endoge- 
nous Mtv-7 and of this new exogenous MMTV, respectively, 
indicates a very high degree of homology in the orf mole- 
cules. The most relevant differences to all the other previ- 
2 Abbreviations used in this paper: MMTV, mouse mammary tumor virus; 
off, open reading frame. 
ously sequenced MMTV off molecules were found in the 
COOH-terminal amino acids, which is compatible with the 
unique Vo specificity of Mls-1 a and this new exogenous 
virus. Since most likely the new MMTV derives from out- 
bred Swiss mice, we propose the designation MMTV (SW). 
Materiah and Methods 
Mice, BALB/c IC mice were purchased from IFFA Credo 
(EArbresle, France), and BALB/c HO mice from Harlan Olac UK 
Ltd. (Bicester, UK). C3H/OuJ and BALB.D2 (43) mice were bred 
in our colony. 
Antibodies. The following mAbs were used in this study: 14.2 
(anti-V~14) (44); 44.22.1 (anti-V~6) (45); KJ-16 (anti-V~8.1-2) (46), 
F23.1 (anti-Va8.1, 8.2, 8.3), F23.2 (anti-V~8.2) (47); KT4.10 (anti- 
Va4) (48); MR 10.2 (anti-V09) (49); TR310 (anti-V~7) (11); 
GK1.5 (anti-CD4) (50), AT 83 (anti-Thy-1) (51). 
Mille Collection, Virus Purification, and Virus Titration. Milk was 
aspirated from lactating BALB/c or C3H/OuJ females after injec- 
tion of 0.5 IU syntocinon/oxytocine (Sandoz, Basel, Switzerland), 
pooled, aliquoted, and stored at -70~ 
Freshly sampled milk was diluted 1:20 with water and centrifuged 
at 600 g for 5 rain to skim and remove casein. Milk serum was 
then centrifuged at 15,000 g for 1 h and the virus pallet was 
resuspended in water (52). 
MMTV gp52 in milk was measured by sandwich ELISA using 
polyclonal sheep and rabbit anti-gp52 IgG (kindly provided by Dr. 
P. Hainaut, University of Liege, Li6ge, Belgium). A biotinylated 
sheep antibody directed against rabbit IgG and streptavidin perox- 
idase served as a detection system. MMTV, purified by ultracen- 
trifugation from the superuatant of cultured GK mammary tumor 
calls, was used as standard. I pg of MMTV corresponds to"o103 
viral particles (40). 
Injections and Sampling. Mouse milk (20 #1), which was either 
MMTV free or contained between 2 x 10 s and 109/#1 MMTV 
(C3H) or (SW) particles, was injected into the hind footpad of 
6-10-wbold BALB/c HO mice. After 4 d, the popliteal and in- 
guinal lymph nodes were isolated. Alternatively, mice were taft bled 
and leukocytes were recovered from heparinized blood samples by 
centrifugation through a Ficoll cushion. Splenic BALB/D2 
Tby-1- cells were prepared by elimination of T cells through com- 
plement lysis using the mAb AT83 (anti-Thy-1), and 6 x 106 cells 
were injected into the footpad. 
FACS | Staining. Lymph node calls or thymocytes (106) were 
stained with anti-TCR Vfl-specific monoclonal hybridoma super- 
natants followed by fluoresceinated anti-rat or anti-mouse IgM 
or IgG antisera. PE-coupled anti-CD4 (GK1.5) (Becton Dickinson 
& Co., Mountain View, CA) was used in the second imension. 
Streptavidin-PE Texas red (Tandem; Southern Biotechnology As- 
sociates, Birmingham, AL) was used to develop the anti-CD8 (Lyt- 
2)-biotin hbeling. Leukocytes were recovered from heparinized blood 
samples by centrifugation through aFicoll cushion. These cells were 
stained in one step with a mixture of FITC-labeled anti-TCK Vfl 
antibody and PE-coupled anti-CD4. 
Dead cells were gated by forward scatter and side scatter anal- 
ysis. Background staining values obtained with the second stage 
reagents alone were subtracted. Analysis was performed on a 
FACScan | (Becton Dickinson & Co.) cell analyzer using logarithmic 
scale for data evaluation. 
Southern Blot Analysis. High-molecular weight genomic tail 
DNA was isolated using standard protocols (53). DNA (10 #g) 
was completely digested by the restriction enzymes EcoKI (Phar- 
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macia, Uppsala, Sweden) or PvulI (Pharmacia), and the DNA frag- 
ments were separated on 0.8% agarose gels using standard condi- 
tions (53). The DNA was transferred on to nylon membranes 
(GcneScreen PLUSH; DuPont Co., Vc'ilmington, DE) by vacuum 
blotting. The baked membranes were prehybridized for a least 2 h 
in 5x SSC, 100/~g/ml salmon sperm DNA, 1% SDS, 5x Den- 
hardt's olution. The DNA probe was radiolabded using the random 
hexamer priming method to ,,~5 x 10 s cpm//~g (54) and then hy- 
bridized with membrane bound DNA for 20 h at 65~ The filters 
were washed in 2x SSC, 0.1% SDS at room temperature then twice 
with 0.2 x SSC, 0.1% SDS at 650C. Autoradiography was for 48 h 
using two intensifying screens and Kodak XAR film. 
Reverse Transcription. Reverse transcription was used to prepare 
viral cDNA. Briefly, partially purified MMTV from milk (~10 9
particles) was added to a reaction mixture containing: lx PCR 
buffer (see below), supplemented with 10 mM DTT, 300 U RNasin 
(Pharmacia), 0.1% NP-40, and 25 U AMV reverse transcriptase 
(Boehringer Mannheim Biochemicals, Mannheim, Germany). The 
reaction was carried out at 42~ for 18 h (55). 
PCR, Clonino~ and Sequencing. The cDNA products of the re- 
verse transcriptase r action were amplified with the two oligonu- 
cleotides spanning the MMTV off region: 5' oligonucleotide: 
GATCGTCGACATC.~CGCGCCTC~AGCAGA; Y oligonudeo- 
tide: GTGTCGACCCAAACCAAGTCAGGAAACCACTTG. 
The oligonudeotides were chosen on the basis of high degrees 
of conservation between the previously sequenced off molecules. 
The conditions for PCR were 1 min at 55~ 1 min at 72~ 1 
min at 93~ for 30 cycles in lx  PCR buffer containing 20 mM 
TRIS-HC1, pH 8.4, 50 mM KC1, 0.2 mM dNTP, 2 mM MgC12, 
0.01% gelatin, 2 U Taq polymerase (AmpliTaq TM, Perkin Elmer 
Corp., EmeryviUe, CA) using an LEP amplifier (SCIENTIFIC 
PREMTM; Lep Scientific Ltd. Milton, Keynes, UK). The PCR 
products were size fractionated in 1% agarose gels and cloned into 
the pGEM3Zf(+) vector (Promega Biotech, Madison, WI) after 
SalI digestion and purification using standard techniques (53). The 
endogenous orf copies were amplified as described above. The 
BALB/D2 high-molecular weight DNA was size fractionated in
agarose gels after complete EcoRI digestion, and the size ranges 
containing Mtv-6 (16.7 kb), Mtv-7 (11.7 kb), and Mtv-9 (10.0 kb) 
were electroeluted (Biotrap; Schleicher & SchfieU, Inc., Keene, NH) 
and treated as the PCR products described above. Recombinant 
plasmids were isolated and used as templates for dideoxy sequencing 
as described (Sequenase Version 2.0; U.S. Biochemical Corp., Indi- 
anapolis, IN). 
Results 
Age-dependent Deletion of V~6 T Cells in Certain BALB,/c 
Mice. In BALB/c mice, Va6 ceils make up ~10%o of pe- 
ripheral CD4 + T cells (4). Upon repeated testing of periph- 
eral blood from a large number of BALB/c mice obtained 
from IFFA-Credo (BALB/c IC), we found an unexpected age- 
dependent clonal deletion of T cells expressing Va6 (Fig. 1). 
At 5 wk of age '~11% ofCD4 + T cells were V~6 + in some 
BALB/c IC mice, however, a considerable fraction of age- 
matched BALB/c IC mice contained only 6% CD4 + Va6 + 
T cells (a similar observation was made by Papiernik et al. 
[56]). In comparison, BALB.D2 mice (which are Mls-1 ' con- 
genic BALB/c mice), had almost completely deleted 
CD4+Va6 + cells from the peripheral blood at 4 wk of age 
(data not shown) (31). At 36 wk of age, the deletion in BALB/c 
IC mice had reached values similar to BALB.D2 mice (i.e., 
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Figure 1. TCR Va6 expression i individual BALB/c IC mice. Mice 
were tested for the presence ofCD4 + V36 + cells in peripheral b ood. Leu- 
kocytes were isolated from heparinized blood by Ficoll density centrifuga- 
tion and stained with a mixture of FITC-labeled anti-Va6 (44.22) and PE- 
coupled anti-CD4 (L3T4) antibody. Analysis was performed ona FACScan | 
Dots represent Va6 values among CD4 + cells for individual BALB/c IC 
or BALB/c HO mice. 
<0.5% CD4+Vo6 + T cells), whereas control values re- 
mained constant at 11% Va6 cells. 
T Cell Repertoire of Individual BALB/c Mice. The only 
genetic element that is known to delete Va6 § T cells is 
Mls-1 '. Besides Va6, however, Mls-l~-positive mice also de- 
lete T cells expressing VO7, V08.1, and VO9 (3, 4, 10, 11). 
Analysis of the peripheral T cell repertoire of Va6-deleting 
BALB/c IC mice showed that among the CD4 + subset VO7, 
as well as Va8.1, expressing T cells were also deleted (Table 
1). The levels of CD4 + Va9 + T cells in BALB/c mice were 
too low to assess whether the deletion was significant. In 
Table 1. TCR Vfl Repertoire of CD4 + T Cells in 
BALB/c Mice 
BALB/c IC 
BALB/c 
HO 3 mo 9 mo BALB.D2 
V/34 6.9 _+ 0.2 8.5 + 0.4 9.8 + 0.2 8.9 + 0.1 
V/36 10.1 _+ 0.2 2.9 _+ 0.2 1.2 + 0.5 0.2 + 0.1 
V/37 2.4 • 0.4 1.7 + 0.4 0.6 _+ 0.2 0.6 -e 0.1 
VB8.1 6.3 _+ 0.8 4.3 • 0.6 3.3 _+ 1.5 0.9 • 0.3 
V/38.2 12.7 • 0.9 12.8 • 0.8 13.2 _+ 0.7 12.5 _+ 1.5 
VB9 1.1 + 0.2 0.8 + 0.2 0.7 + 0.2 0.3 + 0.1 
VB14 8.0 + 1.0 8.2 _+ 1.7 9.0 • 1.1 9.2 • 0.8 
Lymph node cells were analyzed for the TCR V a repertoire using 
FACS | analysis. The lymph nodes from at least hree mice per group 
were analyzed. Data are indicated as mean + SD. 
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addition, deletion of the populations expressing TCR V~3, 
5, and 11 (normally deleted in BALB/c mice) was observed. 
V~8.2 + and V~4 + T cells, which have no known Mls 
specificity, as well as Va14 + T cells that are known to in- 
teract with exogenous MMTVs (C3H) and (GR), were 
unaffected in these mice. Similarly, all other V~s tested (V~2, 
8.3, 10, 13) were unaltered when comparing normal BALB/c 
mice with Va6-deleting BALB/c IC mice (data not shown). 
Among CD4 + T cells, deletion was most obvious for V~6 + 
T cells, whereas Va7 + and V~8.1 + T cells were only par- 
tially deleted in 9-too-old animals. Thus, this deletion ele- 
ment has the same V~ specificity as Mls-1 a. 
Thymic vs. Pe@heral Deletion f V~6 § T Cells. Deletion 
of Vt36 + T cells in Mls-P + strains of mice occurs very rap- 
idly after birth in the thymus (31). In contrast, adult BALB/c 
IC (3 too) mice show only a partial deletion of their Va6 + 
CD4 + and V~6 + CD8 + thymocytes (Table 2). In the pe- 
riphery, CD8 + Va6 + cells are deleted to a lesser degree than 
CD4 + Va6 + T cells (Table 2). The same was true for the 
other Ves affected in BALB/c IC mice (data not shown). 
Exogenous or Endogenous MMTV Since most (if not all) 
known V~ deletion elements are linked to MMTV, we 
hypothesized that the slow Va6 deletion could be caused by 
an endogenous or exogenous MMTV. 
To test the first possibility, we performed Southern blot 
analysis on genomic DNA obtained from Va6 deleting and 
nondeleting BALB/c IC mice. Genomic DNA was either 
digested with EcoRI (data not shown) or PvulI restriction 
endonuclease. Both enzymes generate two diagnostic DNA 
fragments for most integrated viruses. Hybridization of the 
DNA was performed with an MMTV (GR) LTR probe. 
Clearly, fragments corresponding to the BALB/c endoge- 
nous MMTVs (Mtv-6, -8, -9) can be identified in all the mice 
(Fig. 2). However, in a total of 30 BALB/c IC mice tested, 
no new or altered integration site that would correlate with 
the Vt~6 deletion phenotype could be detected. Thus, we 
could exclude a germline-transmitted endogenous MMTV 
as the causative agent for the slow V~6 deletion. 
Table 2. Thymic and Pe@heral Deletion of Vfl6 § T Cells 
Thymus Lymph node 
BALB/c FIO CD4 9.2 +_ 0.2 10.4 _+ 0.3 
CD8 8.3 _+ 1.2 9.7 _+ 0.3 
BALB/c IC CD4 4.4 _+ 0.2 2.9 _+ 0.7 
CD8 2.7 +_ 0.5 5.9 _+ 1.2 
BALB.D2 CD4 0.3 _+ 0.2 0.1 + 0.1 
CD8 0.4 +_ 0.3 0.2 _+ 0.2 
Thymocytes and lymph node cells from 3-mo-old BALB/c IC, BALB/c 
HO, and BALB.D2 mice were analyzed for the presence ofVe6 + T cells 
using three-color FACS | analysis. VO6 expression i the thymus was as- 
sessed by gating on CD4 or CD8 single-positive thymocytes. The lymph 
nodes and thymuses from at least three mice per group were analyzed. 
Data are indicated asmean _+ SD. 
Figure 2. Pattern of endogenous Mtvs in BALB/c IC mice as assessed 
by Southern blot analysis. Tail DNA from V~6 deleting (+) and non- 
deleting (-)  BALB/c IC mice was digested by PvulI. The filter was hy- 
bridized with a MMTV (GR) LTK probe detecting two fragments for 
every endogenous Mw contained in BALB/c mice. Arrows to the fight 
indicate molecular weight markers of 23.1, 9.4, 6.6, 4.4, 2.3, and 2,2 kb. 
Arrows to the left indicate he Mtv fragments. The two fragments of Mtv-7 
would migrate at >20 kb (3') and 2.5 kb (5') (data not shown; 36). 
Exogenous MMTVs can be inherited through transmis- 
sion from mother to offspring via milk. This maternal trans- 
mission of MMTV (C3H) has been shown to result in dele- 
tion of CD4+V~14 + T cells (33). We therefore bred 
BALB/c IC female mice that had deleted V~6 + T cells with 
nondeleter BALB/c IC males. The offspring of these crosses 
had all inherited the Vt~6-deleter phenotype (data not 
shown). To directly test milk from this mother for exoge- 
nous MMTV, we used an ELISA system to detect he MMTV 
envelope protein gp52 in milk. As shown in Fig. 3, milk 
from this Vo6-deleting BALB/c IC mother contained as 
much gp52 as milk obtained from lactating C3H/OuJ mice, 
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Figure 3. Presence ofMMTV in milk samples. Milk samples were tested 
for the presence of exogenous MMTV. Polyclonal sheep anti-gp52 IgG 
was used as a capture antibody for MMTV contained in C3H milk (O), 
BALB/c IC milk (m), or BALB/c HO milk (A). Rabbit anti-gp52 was 
then used to detect he immobilized MMTV. 
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which contain high titers of MMTV (C3H). All BALB/c 
IC deleter females tested showed high titers of MMTV in 
their milk (data not shown), whereas no gp52 was detected 
in BALB/c HO milk. This is in agreement with earlier reports 
that normal BALB/c mice do not contain detectable MMTV 
particles in milk (57). Since 1 pg of MMTV corresponds to
,~1,000 virus particles (40), and purified MMTV (GR) was 
used as a standard, we could estimate the detection limit of 
the ELISA to be <2 x 104 MMTV particles per microliter 
of milk. Milk from C3H or from Va6-deleting BALB/c IC 
mice contained usually between 10 s and 109 MMTV parti- 
cles per microliter of milk. From now on we refer to this 
new MMTV as MMTV (SW) (see Discussion). 
In Vivo Response toMMTV ($W). To test whether the 
MMTV (SW) particles could affect Va6 + T cells in vivo, 
Table 3. The Exogenous MMTV (SI'V) and Mls-1 ~ B Cells 
Induce CD4 § VB6 + T Cell Increase In Vivo 
Percent Vfl among CD4 + 
T cells 
Injection No. V~6 V/38.2 VB14 
No injection 1 11.1 12.0 10.0 
2 12.0 12.0 9.4 
3 11.8 14.0 11.5 
BALB/C HO milk 1 10.9 13.2 10.8 
2 10.5 12.5 9.9 
C3H-milk 1 9.3 11.4 12.6 
2 9.5 11.5 11.5 
3 9.1 11.3 13.5 
BALB/c IC milk 1 27.8 7.5 6.7 
2 30.7 7.6 6.7 
3 30.3 ND 8.1 
BALB/c HOB cells 1 11.6 13.2 ND 
2 13.1 ND 10.8 
3 12.2 ND 10.6 
BALB/c IC B cells 1 12.2 13.6 ND 
2 13.8 ND 11.0 
3 12.8 ND 11.0 
BALB.D2 B cells 1 43.8 7.7 ND 
2 31.2 ND 8.7 
3 39.4 ND 8.3 
Milk (20/zl) containing 4 x 109 to 101~ virus particles or 6 x 10 # 
splenic B cells were injected into the footpads of BALB/c HO mice. Af- 
ter 4 d, the percentage ofcells expressing the indicated TCR V a chains 
among the CD4* cells in the popliteal and inguinal ymph nodes was 
determined by FACS* analysis. Results from individual mice are shown. 
Values showing significant increases are underlined. 
we injected 20/~1 milk, i.e., "~4 x 109 virus particles, in the 
hind foot pads of normal adult BALB/c HO mice. As con- 
trols, BALB/c HO mice were either injected with milk con- 
taining MMTV (C3H) (4 x 109 to 4 x 1010 particles) or 
milk from control BALB/c HO mice (not containing detect- 
able MMTV particles). 
To follow the events after virus challenge, we analyzed the 
popliteal and inguinal lymph nodes. Results obtained with 
exogenous virus indicated that 4 d after injection was an ap- 
propriate time point to analyze the local immune response. 
Milk containing the C3H virus induced only a marginal 
increase of TCK Va14-expressing T cells in the local lymph 
nodes of the injected footpad compared with noninjected con- 
trol mice. No alteration i  the Va profile was observed with 
control milk. However, injection of the milk from Va6 
deleters induced astrong specific increase of V~6 cells from 
10% to •30% of CD4 + T cells (Table 3). 
Since it is a distinct feature of Mls-1 a B cells to induce a 
strong proliferative response of T cells from Mls-P- 
nonexpressing mice (1, 28-30), we similarly injected Mls-1 a 
B calls into the footpad. Again, CD4+Va6 + T ceils in- 
creased when BALB/c HO mice were injected with BALB.D2 
(Mls-l') splenic B cells. No specific increase, however, was 
observed when B calls from BALB/c IC Va6 deleters or 
BALB/c HO mice were injected (Table 3). Furthermore, B 
cells from VB6 ddeters were unable to stimulate a prolifera- 
tive response of Va6 + cells in vitro or to induce II.,2 produc- 
tion by the Va6 + T ceil hybrid RG-17 (data not shown). 
It has been shown for staphylococcal enterotoxins (SE) and 
Table 4. MMTV (SW) Induces Deletion of CD4 § 
V~6 § T Cells 
Time after injection 
Injection No. 4 d 14 d 40 d 
BALB c HO milk V~6 1 9.5 11.2 10.8 
2 9.9 11.1 I1.1 
V~14 1 9.6 9.4 10.2 
2 9.6 9.1 9.8 
C3H milk V~6 1 10.3 11.4 12.7 
2 11.2 13.0 12.6 
V~14 1 8.3 7.2 5.5 
2 8.8 6.8 4.8 
BALB/c IC milk V~6 1 6.7 3.3 1.5 
2 7.2 3.6 1.6 
V/~/14 1 9.8 10.3 ND 
2 11.7 10.7 11.5 
Mice were injected with milk as described in the legend to Table 3. At 
the indicated time points the percentage ofV~6 + and V~14 + T cells in 
the CIM + subset was determined in the peripheral blood by FACS ~ 
analysis. Results of individual mice are shown. 
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Mls-1 ~ that upon injection in vivo, the initial proliferation 
of T cells is followed by a state of nonresponsiveness andpar- 
tial peripheral deletion of the reactive T cells (13, 58, 59). 
Thus, we tested blood samples various times after virus in- 
jection for the presence of CD4+Va6 + and CD4+Vo14 + T 
cells. At 4 d, a small but significant reduction of Va6 + T 
cells was observed in mice injected with MMTV (SW)-con- 
taining milk (Table 4). This could have been due either to 
recruitment of these cells to the local lymph node and/or 
the onset of donal deletion. The reduction of CD4 +Va6 + 
T cells in peripheral blood reached 75% after 2 wk and was 
almost complete after 6 wk (1.5% of CD4 + T cells). 
MMTV (C3H) did not induce a specific reduction of 
CD4+Va14 + cells 2 wk after injection. After 6 wk, how- 
ever, C3H milk induced aspecific reduction of CD4 + Va14 + 
T cells, which did not exceed 50%. Values for CD4+Vt36 +
and CD4+Va14 + T cells remained unchanged in mice in- 
jected with control milk. Thus, both viruses induced ele- 
tion of the expected Vas from the peripheral T cell pool 
upon local injection into the footpad. 
Purification of the Exogenous Virus and Cloning of MMTV 
(SW) o~ We partially purified the novel MMTV contained 
in milk of Va6 deleters. Reverse transcription was used to 
prepare cDNA from the viral KNA. The off molecule in 
the 3' LTK has recently been shown to mediate the Va 
specificity in both exogenous MMTV (C3H) (39) and (GK) 
(32). Therefore, we used the PCR with primers to conserved 
regions panning the off coding region to amplify a 1.1-kb 
stretch of the 3' LTK containing the entire orf sequence. The 
PCK products were then cloned and sequenced. In addition 
to BALB/c IC milk, a PCK product was obtained from C3H 
milk. However, no PCK product was obtained from the con- 
trol BALB/c HO milk. 
Sequence analysis revealed that the 3' LTK from the novel 
exogenous MMTV (SW) is very similar to other described 
MMTV sequences at the 5' end of the off (Fig. 4). However, 
a stretch with a unique sequence was found at the 3' end, 
altering the last 21 amino acids of the putative orf protein 
completely. 
Cloning of Mtv-7 off (Mls-la). Since the novel MMTV 
(SW) has the identical V~ spedficity as Mls-1 ~, and a strong 
linkage between endogenous Mls-1 ~ and Mtv-7 has been ob- 
served (32, 36), we attempted todone Mtv-7. To this end, 
genomic DNA isolated from BALB.D2 spleen was digested 
with the restriction endonuclease EcoKI and size fraction- 
ated on an agarose gel. DNA was subsequently isolated from 
gel slices corresponding to the Y ends of Mtv-9 (10.0 kb), 
Mtv-7 (11.7 kb), and Mtv-6 (16.7 kb). (38) PCK analysis was 
then performed with primers that can amplify all known 
MMTV off sequences. 
Nudeotide sequences ofclones derived from PCK prod- 
ucts obtained from the Mtv-9 fraction were nearly identical 
to the published Mtv-9 LTK off sequence (Fig. 5, and data 
not shown). However, clones obtained from the Mtv-7 and 
Mtv-6 fractions howed striking differences atthe 3' end of 
the LTK, as compared with previously published sequences 
(Fig. 4). The putative Mtv-7 sequence was very similar to 
the exogenous virus sequence d scribed above. At the extreme 
3' end of the orf coding region, which is very different from 
all known MMTV off sequences (and is thought to mediate 
the V~ specificity), Mtv-7 and the novel virus display ex- 
tremely high sequence homology, except for only three con- 
servative amino acid differences (Fig. 5). 
Discussion 
With the discovery that Mls antigens are encoded by en- 
dogenous Mtv proviral oci, experiments using exogenous 
MMTV to analyze infection, tolerance development, and the 
interplay between the immune system and cancer develop- 
ment have become possible. This sort of analysis has been 
hampered by the fact that only two exogenous MMTVs have 
been characterized in sufficient detail so far, namely the 
MMTVs (C3H) and (GR) (32, 39). Both of these viruses 
behave very similarly to the Mls-like antigens that are slow 
deleters and weak stimulators in a mixed lymphocyte r ac- 
tion. They can be presented only by MHC I-E molecules 
and affect T cells expressing V~14. With the description of 
MMTV (SW) in this article, a virus with biological proper- 
ties very similar to Mls-1 a, we found the exogenous coun- 
terpart of a strong Mls determinant. 
One of the most prominent features of Mls-1 ' is the 
strong proliferative r sponse of T cells from Mls-l~-negative 
mice to Mls-l'-expressing B cells (1, 28-30). In that respect, 
Mls-1 ' is the strongest of all the Mls determinants. In this 
study we show that this feature, however, was not found in 
B cells from mice maternally infected with the Mls-l'-like 
exogenous MMTV (SW). Several explanations could account 
for this discrepancy. (a) The amino acid sequence compar- 
ison between the exogenous and the endogenous virus indi- 
cates a few minor differences atthe COOH terminus of the 
off molecule. However, these changes inthe COOH terminus 
of the exogenous (Mtv-7-1ike) orf compared with Mtv-7 are 
conservative, and thus unlikely to account for an inefficient 
interaction with the TCR VS. The two most likely expla- 
nations are: (b) the frequency of MMTV-infected B cells could 
be too low to induce a stimulation. In control mixing ex- 
periments, 3% Mls-l' expressing BALB/D2 B cells are re- 
quired to induce a detectable mixed lymphocyte r action 
(H. R. MacDonald, unpublished observations). (c) The ex- 
pression level of the MMTV off protein could be too low 
to induce a strong stimulation. However, injected in vivo, 
the novel virus is almost as efficient as Mls-P B cells at trig- 
gering Vo6 + T cells. In comparison, exogenous C3H virus 
is not able to stimulate V~14-expressing T cells in the same 
assay. By this criterion, the novel MMTV encodes astrong 
Mls determinant. 
It is striking that, in vivo, MMTV (C3H) and the novel 
MMTV induce a slow deletion of T cells expressing their 
target Vas in mice that take up the virus by suckling. Al- 
though both the thymus and the periphery show deletion 
of V~6 + T cells in infected mice, peripheral deletion of 
CD4 + V~6 + T cells is more profound, suggesting that some 
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Figure 4. Nucleotide and amino 
acid sequences of MMTV (SW) off 
and Mtv- 7 off. In the Mtv-7 nucleo- 
tide sequence, the nudeotides iden- 
tical with the MMTV (SW) se- 
quence are indicated in dashes. 
Below the Mw-7 nudeotide sequence, 
the differences in the MW-7 off 
amino acid sequences are indicated. 
The amino acids are written in the 
single-letter code. The sequences of 
the oligonucleotides used for am- 
plification are underlined. The se- 
quence data are available from 
EMBL under accession numbers 
X65339 and X65340. 
virus-infected cells may recirculate to the thymus in the 
neonate. 
With both viruses it takes several months until the dele- 
tion is complete. When introduced into adults by foot pad 
injection, the C3H virus again induces a slow, 50% reduc- 
tion of Va14 § cells, whereas the novel Mls-l'-like virus in- 
duces a very rapid and almost complete deletion of Va6 § T 
cells. This apparent discrepancy might be explained by a very 
inefficient uptake of the latter virus through the gut, and 
argues against a weak stimulation potential of the exogenous 
virus. Since virus uptake may be dependent upon the enve- 
lope protein gp52, detailed analysis of the gpS2 sequence may 
be required to test this hypothesis. 
The incidence os mammary tumors induced in BALB/c 
mice foster nursed to C3H mothers is very high (80-90%) 
at 1 yr of age (60). In contrast, in our BALB/c IC colony 
we did not observe a single mammary tumor so far. Even 
old (>1 yr) breeders (. -- 20) that had several litters did not 
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Figure 5. Amino acid sequence 
comparison of the known off se- 
quences. The COOH-terminal 70 
amino adds, which contain the most 
polymorphic residues, are shown. 
The orf sequences are grouped in 
families as depicted on the left, ac- 
cording to the deletion of the indi- 
cated TCR Ve-expressing T cells. 
The sequences for BR-6, Mtv.l, .8, 
-II, -17, and for MMTV (GR), 
(C3H), and (C3H-K) are from the 
literature (29, 32, 73-79). The 
Mtv-6,-7,-9, and MMTV (SW) off 
sequences were derived in this study. 
develop tumors. Thus, on the same genetic background, mam- 
mary tumor induction isonly observed with MMTV (C3H), 
although MMTV (SW) deletes Vt3s as profoundly as 
MMTV (C3H). This suggests that the tumor-inducing ca- 
pacity of MMTV is not reflected in its efficiency to delete 
V~s. 
The question about he origin of this exogenous virus re- 
mains open. BALB/c IC mice were derived from BALB/c 
J mice, when a breeding colony was established in 1988 at 
IFFA Credo. A genetic ontamination is very unlikely since 
the endogenous MMTV copies are identical to standard 
BALB/c mice and because the colony is regularly tested for 
skin graft rejection with BALB/c J skin. No rejections have 
been observed. Mice with Mls-l'-like determinants have 
never been reported in the BALB/c J colony. Thus, the most 
likely means of MMTV infection is maternally through milk. 
The BALB/c IC breeding pairs were derived from BALB/c 
J mothers by Caesarian section and fostered to outbred Swiss 
foster mothers. Therefore, two major possibilities might ex- 
plain the origin of this exogenous Mls-l'-like virus: one is 
that it represents he original MMTV, which upon integra- 
tion is found as Mtv-7 in several laboratory mouse strains. 
Since many outbred Swiss mice have the H-2q haplotype, 
Figure 6. Amino acid sequence homology between Mtv-7 orf, MMTV 
(SW) orf, and $100 proteins. Similarity be ween sequences was determined 
using the program Bestfit from the Genetics Computer Group (GCG) 
package (80). A stretch of 28 and 29 amino acids was analyzed for Cal- 
pactiu pll and 18A2, respectively. Numbering of amino acids is according 
to Fig. 5 for or{ molecules andreference 69 for $100 proteins. Identical 
amino acids are shown in bold characters and asterisks indicate th COOH 
termini of the off molecules. The helix-loop-helix motif of $100 proteins 
described inreference 70 is superimposed onto the Mw-7 and MMTV (SW) 
off sequences. 
which is not able to present Mls antigens (15), the exoge- 
nous virus would not have been detected by analysis of Vo6 
expression (3, 4, 10). Alternatively, MMTV (SW) originates 
from Mtv-7. After formation of infectious particles from the 
integrated provirus, production of infectious particles in milk 
can occur. Several examples for this possibility exist in the 
literature. Mtv-I and Mtv-2 can form infectious virus particles 
that are then transmitted tooffspring through the milk and 
through the germline (61-63). Normal mice not containing 
Mtv-I and Mtv-2 can form mammary tumors, which are most 
likely due to other endogenous MMTV, after 1 yr of age 
(57). Furthermore, treatment oflaboratory mouse strains or 
mouse cell lines with irradiation and/or carcinogens can lead 
to formation of infectious MMTV particles (64-68). Although 
further experiments are required to definitively settle this ques- 
tion, it seems likely that the virus was transmitted to BALB/c 
IC mice from outbred Swiss mice. Hence, we propose the 
designation MMTV (SW) for this virus. 
Since most of the divergence in MMTV orf sequences re- 
sides in the COOH terminus of the putative off protein, it 
has been argued that the COOH terminus confers V~ 
specificity (27, 32, 39). It was recently shown that the off 
molecule of Mtv-7 is responsible for deletion of Mls-1 a- 
reactive T cells (68@ and that the off molecule of Mtv-9 is 
responsible for deletion of Va5 and V~11 T cells (69). For 
Mtv-7 (and the homologous novel exogenous MMTV [SW]), 
the COOH terminus i very different from previously pub- 
lished off sequences. An additional rgument for the impor- 
tance of the COOH terminus in determining the V0 spec- 
ificity is that off of Mtv-6, a gene encoding Mls-3 a (a dele- 
tion element for TCR Va3), is identical to the off sequence 
of Mtv-1, another VO3 deleter (Fig. 5). The off molecules 
that are implicated in clonal deletion of T cells fall into four 
groups, each specific for a particular subset of T cells expressing 
(a) specific VO region(s). With the nine MMTV off mole- 
cules sequenced so far, which correspond toone of four TCR 
VO specificities, an excellent correlation exists between the 
COOH-terminal orf sequence and TCR Vt~ specificity. In 
addition, we have shown in experiments u ing transgenic mice 
that a variant of MMTV (C3H) with a dramatically altered 
off COOH terminus, failed to induce deletion of TCR 
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V~14. The key residues within the COOH terminus re- 
quired for orf-TCR interaction remain to be defined. 
Analysis of sequence homology of entire orf molecules did 
not reveal any significant homologies with sequences in the 
database. When the unique COOH terminus of the Mtv-7 
and MMTV (SW) orfs were compared with the "Swissport" 
data base, however, significant homologies to two members 
of the $100 protein family were found: the calpactin L chain 
pll and 18A2 (see Fig. 6) (for review see reference 70). $100 
proteins display a common structural feature termed EF hand. 
This is a helix-loop-helix structure that has in its original 
form calcium-binding capacity (71). The homology of Mtv-7 
and MMTV (SW) off is located in the COOH-terminal EF 
hand spanning the first E helix (nine amino acids) and the 
loop (12 amino acids). The COOH-terminal off residue 
(phenylalanine) corresponds to the first amino acid of the 
second, F helix (Fig. 6). Biochemical evidence suggests that 
this particular EF hand in the calpactin L chain does not bind 
calcium anymore (72). 
These findings might suggest that the Mtv-7 and MMTV 
(SW) orf molecules have a COOH terminus forming a helix- 
loop configuration. Since the polymorphic COOH terminus 
has been implicated in Va specificity of the off molecules, 
it might be this loop of 12 amino acids that confers the binding 
to the Vo domain of the TCR. 
The existence of exogenous MMTV (and their endoge- 
nous counterparts) with different TCR V~ specificity and 
kinetics of clonal deletion provides apowerful tool to inves- 
tigate the different phases of peripheral nd thymic tolerance 
mechanisms. The timing of deletion can be controlled with 
dose, route of infection, and choice of virus. Neonatal and 
adult immune response and tolerance can be compared. In 
addition, after local administration, the spread of the virus 
in the immune system and to the mammary gland can be 
analyzed in much greater detail. 
With the finding of this Mls-l'-like exogenous MMTV 
(SW), it seems likely that many more exogenous MMTV 
viruses may exist in the wild (and laboratory) mouse popula- 
tion. Analysis of the milk of different strains of mice will 
give indications about he frequency and heterogeneity of such 
viruses. Potentially, MMTVs with many different TCR 
specificities can be found. Sequence analysis of the orf cDNA 
and comparison with TCR deletion patterns will give in- 
sight into important residues for TCR and MHC interaction. 
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